. 2022 Feb 13;62(3):705–712. doi: 10.47162/RJME.62.3.07

Table 2.

Distribution of BCC and SCC according to the number of positive cases and the average values of FSS for E-cadherin, fibronectin and Slug

NMSC	BCC					SCC
	*LRG*		*HRG*		*χ² test*	*HGD*		*LGD*		*χ² test*
	No. of cases	FSS	No. of cases	FSS	*χ² test*	No. of cases	FSS	No. of cases	FSS	*χ² test*
E-cadherin
pT1	10	8	5	6	p<0.001	6	12	3	4	p=0.117
pT2	6	6	2	6		2	6	1	1
pT3	4	6	–	–		2	6	1	1
pT4	–	–	–	–		–	–	–	–
χ² test	p=0.003					p=0.004
Fibronectin
pT1	–	–	–	–	p=0.001	–	–	–	–	p<0.001
pT2	–	–	–	–		1	3	2	4
pT3	–	–	1	1		2	3	2	9
pT4	–	–	1	1		–	–	1	9
χ² test	p=0.038					p=0.311
Slug
pT1	2	2	4	7	p=0.041	1	1	2	7	p=0.024
pT2	5	9	2	10		2	5	2	10.5
pT3	4	11	1	12		2	6	2	12
pT4	–	–	1	12		–	–	1	12
χ² test	p=0.350					p=0.034

BCC: Basal cell carcinoma; FSS: Final staining score; HGD: High grade of differentiation; HRG: High-risk grade; LGD: Low grade of differentiation; LRG: Low-risk grade; NMSC: Non-melanoma skin cancer; pT: Primary tumor; SCC: Squamous cell carcinoma